Data demonstrate efficacy of more flexible dose of regorafenib to relieve side-effects in mCRC patients

ScienceDaily
Jul 6, 2019, 12:34 pm1k ptsInterestingTop
Some of the adverse events related to the use of regorafenib often limits its use in clinical practice. A study suggests the usefulness of a more flexible dosing, which improves patients' quality of life without jeopardizing efficacy.

Read Article Share
Share Article
- email
- x.com
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on EcoTopical

Over 3,000 One-Megawatt EV Charging Stations Planned By BYD For Europe 126

Tiny Texas School District Rejects Tax Deal with $6 Billion LNG Project 126

Cameroon’s decade of conflict leaves apes and conservationists in peril 124

Report shows progress towards even cleaner EV supply chains, Tesla leads 123

Urban trees can absorb more CO₂ than cars emit on some summer days, Munich study shows 122

No grid, no problem: How Amazon communities built their own power systems 118

Ferries emit ‘more sulphur pollution than cars’ in several EU capitals 113

Study finds 77% of US national parks are highly vulnerable to climate change 113

About EcoTopical

Welcome to EcoTopical Your daily eco-friendly green news aggregator.

Leaf through planet Earths environmental headlines in one convenient place. Read, share and discover the latest on ecology, science and green living from the web's most popular sites.